Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: Evidence from the Ovarian Cancer Association Consortium

British Journal of Cancer

Volumn 115, Issue 1, 2016, Pages 95-101

  Cannioto, Rikki A ^a   LaMonte, Michael J ^b   Kelemen, Linda E ^c   Risch, Harvey A ^d   Eng, Kevin H ^a   Minlikeeva, Albina N ^a,b   Hong, Chi Chen ^a   Szender, J Brian ^a   Sucheston Campbell, Lara ^a   Joseph, Janine M ^a   Berchuck, Andrew ^e   Chang Claude, Jenny ^f,g   Cramer, Daniel W ^h   De Fazio, Anna ⁱ   Diergaarde, Brenda ^j   Dörk, Thilo ^k   Doherty, Jennifer A ^l   Edwards, Robert P ^m,n   Fridley, Brooke L ^o   Friel, Grace ^p   Goode, Ellen L ^q   Goodman, Marc T ^r   Hillemanns, Peter ^k   Hogdall, Estrid ^s,t   Hosono, Satoyo ^u   Kelley, Joseph L ^m   Kjaer, Susanne K ^s,t   Klapdor, Rudiger ^k   Matsuo, Keitaro ^u   Odunsi, Kunle ^a   Nagle, Christina M ^v   Olsen, Catherine M ^v   Paddock, Lisa E ^w   Pearce, Celeste L ^x   Pike, Malcolm C ^y   Rossing, Mary A ^z   Schmalfeldt, Barbara ^g   Segal, Brahm H ^a   Szamreta, Elizabeth A ^w   Thompson, Pamela J ^r   Tseng, Chiu Chen ^aa   Vierkant, Robert ^q   Schildkraut, Joellen M ^ab   Wentzensen, Nicolas ^ac   Wicklund, Kristine G ^z   Winham, Stacey J ^q   Wu, Anna H ^aa   Modugno, Francesmary ^j,m,n   Ness, Roberta B ^ad   Jensen, Allan ^s   Webb, Penelope M ^v   Terry, Kathryn ^h   Bandera, Elisa V ^w   Moysich, Kirsten B ^a   more..

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d YALE UNIVERSITY   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^k HANNOVER MEDICAL SCHOOL   (Germany)

^l DARTMOUTH MEDICAL SCHOOL   (United States)

^m UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁿ UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^o UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^p Independent Health   (United States)

^q MAYO CLINIC   (United States)

^r CEDARS SINAI MEDICAL CENTER   (United States)

^s DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^t UNIVERSITY OF COPENHAGEN   (Denmark)

^u AICHI CANCER CENTER HOSPITAL   (Japan)

^v QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^w RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^x UNIVERSITY OF MICHIGAN   (United States)

^y MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^z USA   (United States)

^aa UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^ab UNIVERSITY OF VIRGINIA   (United States)

^ac NATIONAL CANCER INSTITUTE   (United States)

^ad UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

epithelial ovarian cancer; inactivity; mortality risk; recreational physical activity; survival

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MORTALITY RISK; OVARY CARCINOMA; PHYSICAL INACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; EXERCISE; MIDDLE AGED; MORTALITY; NEOPLASM; OVARY TUMOR; PHYSIOLOGY; RECREATION; RISK FACTOR;

EXERCISE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RECREATION; RISK FACTORS;

EID: 84974670733     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2016.153     Document Type: Article

References (34)

1. Akeson M, Jakobsen AM, Zetterqvist BM, Holmberg E, Brannstrom M, Horvath G. (2009). A population-based 5-year cohort study including all cases of epithelial ovarian cancer in western Sweden: 10-year survival and prognostic factors. Int J Gynecol Cancer 19(1): 116-123
2. Bandera EV, King M, Chandran U, Paddock LE, Rodriguez-Rodriguez L, Olson SH. (2011). Phytoestrogen consumption from foods and supplements and epithelial ovarian cancer risk: a population-based case control study. BMC Womens Health 11: 40
3. Berchuck A, Schildkraut JM, Pearce CL, Chenevix-Trench G, Pharoah PD. (2008). Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium. Adv Exp Med Biol 622: 53-67
4. Bodelon C, Cushing-Haugen KL, Wicklund KG, Doherty JA, Rossing MA. (2012). Sun exposure and risk of epithelial ovarian cancer. Cancer Causes Control 23(12): 1985-1994
5. Bull FC, Armstrong TP, Dixon T, Ham S, Neiman A, Pratt M. (2004). Physical inactivity. In Comparitive Quantification of Health Risks: Global and Regional Burden of Disease Attributable to selected Major Risk Factors, WHO (ed), Vol. 1, Chapter 10. World Health Organization: Geneva, Switzerland, pp 729-881
6. Byers T. (2014). Physical activity and gastric cancer: so what? An epidemiologist's confession. Cancer Prev Res (Phila) 7(1): 9-11
7. Celis-Morales CA, Perez-Bravo F, Ibanez L, Salas C, Bailey ME, Gill JM. (2012). Objective vs self-reported physical activity and sedentary time: effects of measurement method on relationships with risk biomarkers. PloS One 7(5): e36345
8. Cress RD, Chen YS, Morris CR, Petersen M, Leiserowitz GS. (2015). Characteristics of long-Term survivors of epithelial ovarian cancer. Obstet Gynecol 126(3): 491-497
9. Fiuza-Luces C, Garatachea N, Berger NA, Lucia A. (2013). Exercise is the real polypill. Physiology (Bethesda) 28(5): 330-358
10. Glud E, Kjaer SK, Thomsen BL, Hogdall C, Christensen L, Hogdall E, Bock JE, Blaakaer J. (2004). Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Arch Intern Med 164(20): 2253-2259
11. Goode EL, Chenevix-Trench G, Hartmann LC, Fridley BL, Kalli KR, Vierkant RA, Larson MC, White KL, Keeney GL, Oberg TN, Cunningham JM, Beesley J, Johnatty SE, Chen X, Goodman KE, Armasu SM, Rider DN, Sicotte H, Schmidt MM, Elliott EA, Hogdall E, Kjaer SK, Fasching PA, Ekici AB, Lambrechts D, Despierre E, Hogdall C, Lundvall L, Karlan BY, Gross J, Brown R, Chien J, Duggan DJ, Tsai YY, Phelan CM, Kelemen LE, Peethambaram PP, Schildkraut JM, Shridhar V, Sutphen R, Couch FJ, Sellers TA. (2011). Assessment of hepatocyte growth factor in ovarian cancer mortality. Cancer Epidemiol Biomarkers Prev 20(8): 1638-1648
12. Goode EL, Maurer MJ, Sellers TA, Phelan CM, Kalli KR, Fridley BL, Vierkant RA, Armasu SM, White KL, Keeney GL, Cliby WA, Rider DN, Kelemen LE, Jones MB, Peethambaram PP, Lancaster JM, Olson JE, Schildkraut JM, Cunningham JM, Hartmann LC. (2010). Inherited determinants of ovarian cancer survival. Clin Cancer Res 16(3): 995-1007
13. Goodman MT, Lurie G, Thompson PJ, McDuffie KE, Carney ME. (2008). Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk. Endocr Relat Cancer 15(4): 1055-1060
14. Hallal PC, Andersen LB, Bull FC, Guthold R, Haskell W, Ekelund U. (2012). Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet 380(9838): 247-257
15. Hamajima N, Matsuo K, Saito T, Hirose K, Inoue M, Takezaki T, Kuroishi T, Tajima K. (2001). Gene-environment interactions and polymorphism studies of cancer risk in the hospital-based epidemiologic research program at Aichi Cancer Center II (HERPACC-II). Asian Pac J Cancer Prev 2(2): 99-107
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. (2003). Measuring inconsistency in meta-Analyses. BMJ 327(7414): 557-560
17. Hildebrand JS, Gapstur SM, Gaudet MM, Campbell PT, Patel AV. (2015). Moderate-To-vigorous physical activity and leisure-Time sitting in relation to ovarian cancer risk in a large prospective US cohort. Cancer Causes Control 26(11): 1691-1697
18. Kelemen LE, Goodman MT, McGuire V, Rossing MA, Webb PM, Kobel M, Anton-Culver H, Beesley J, Berchuck A, Brar S, Carney ME, Chang-Claude J, Chenevix-Trench G, Cramer DW, Cunningham JM, Dicioccio RA, Doherty JA, Easton DF, Fredericksen ZS, Fridley BL, Gates MA, Gayther SA, Gentry-Maharaj A, Hogdall E, Kjaer SK, Lurie G, Menon U, Moorman PG, Moysich K, Ness RB, Palmieri RT, Pearce CL, Pharoah PD, Ramus SJ, Song H, Stram DO, Tworoger SS, Van Den Berg D, Vierkant RA, Wang-Gohrke S, Whittemore AS, Wilkens LR, Wu AH, Schildkraut JM, Sellers TA, Goode EL. (2010). Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 19(7): 1822-1830
19. Li T, Wei S, Shi Y, Pang S, Qin Q, Yin J, Deng Y, Chen Q, Nie S, Liu L. (2016). The dose-response effect of physical activity on cancer mortality: findings from 71 prospective cohort studies. Br J Sports Med 50(6): 339-345
20. Lo-Ciganic WH, Zgibor JC, Bunker CH, Moysich KB, Edwards RP, Ness RB. (2012). Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer. Epidemiology 23(2): 311-319
21. Maldonado G, Greenland S. (1993). Simulation study of confounder-selection strategies. Am J Epidemiol 138(11): 923-936
22. McTiernan A. (2008). Mechanisms linking physical activity with cancer. Nat Rev Cancer 8(3): 205-211
23. Merritt MA, Green AC, Nagle CM, Webb PM. (2008). Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer 122(1): 170-176
24. Risch HA, Bale AE, Beck PA, Zheng W. (2006). PGR 331A/G and increased risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 15(9): 1738-1741
25. Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS. (2007). Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 16(12): 2548-2556
26. Sanchis-Gomar F, Lucia A, Yvert T, Ruiz-Casado A, Pareja-Galeano H, Santos-Lozano A, Fiuza-Luces C, Garatachea N, Lippi G, Bouchard C, Berger NA. (2015). Physical inactivity and low fitness deserve more attention to alter cancer risk and prognosis. Cancer Prev Res (Phila) 8(2): 105-110
27. SEER. (2014). SEER Stat Fact Sheets: Ovary Cancer. In SEER Stat Fact Sheets Vol. 2014. National Cancer Institute: Bethesda, MD, USA. Available at http://seer.cancer.gov/statfacts/html/ovary.html
28. Terry KL, De Vivo I, Titus-Ernstoff L, Shih MC, Cramer DW. (2005). Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk. Cancer Res 65(13): 5974-5981
29. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. (2015). Global cancer statistics, 2012. CA Cancer J Clin 65(2): 87-108
30. UK CR. (2015). Ovarian Cancer Statistics. Cancer Research UK: London
31. USDHHS. (2008). 2008 Physical Activity Guidelines for Americans. Office of Disease Prevention and Health Promotion: Washington, DC, USA
32. Winter III WE, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, Markman M, Armstrong DK, Muggia F, McGuire WP. (2007). Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 25(24): 3621-3627
33. Wright JD, Chen L, Tergas AI, Patankar S, Burke WM, Hou JY, Neugut AI, Ananth CV, Hershman DL. (2015). Trends in relative survival for ovarian cancer from 1975 to 2011. Obstet Gynecol 125(6): 1345-1352
34. Wu AH, Pearce CL, Tseng CC, Pike MC. (2015). African Americans and Hispanics remain at lower risk of ovarian cancer than Non-Hispanic Whites after considering nongenetic risk factors and oophorectomy rates. Cancer Epidemiol Biomarkers Prev 24(7): 1094-1100